Privacy Authority Sample Clauses

Privacy Authority. Distributor irrevocably authorizes Zeltiq, its employees and agents to make such inquiries as it deems necessary to investigate the credit worthiness or other information requirements of Distributor from time to time including the making of inquiries of persons that are trade references, the bankers of Distributor or any other credit providers (collectively the “Information Sources”) and Distributor hereby authorizes the Information Sources to disclose to Zeltiq such information concerning Distributor.
AutoNDA by SimpleDocs
Privacy Authority. (a) For the purposes of assessing your creditworthiness, you irrevocably authorise us, our servants and agents to make such enquiries as we deem necessary for this purpose, including without limitation, making enquiries with and obtaining such reports as may be allowed by law from:
Privacy Authority. 11.1. Where the Purchaser applies for credit with Sandvik, the Purchaser agrees and authorises Sandvik to make such enquiries as Sandvik deems necessary to assess the Purchaser’s application for credit. The Purchaser further agrees and authorises Sandvik no event does Sandvik give any warranty to parts or components manufactured and/or supplied by any third party.
Privacy Authority. The Third Party hereby irrevocably authorise RLSSQ to provide information (both verbal and written) and any document in respect to the Third Party: • In a public forum or on social media, • To ASQA or any related training authority, • To our other trainers, contractors, business partners & affiliates, and/or • To any government agency (including the ACNC and the State & Federal Governments) as RLSSQ considered is necessary for the operation and reporting of RLSSQ 26. DISPUTE RESOLUTION (a) If a dispute arises from this Agreement, a party to the Agreement must not commence court or arbitration proceedings relating to the dispute without first attempting to resolve the dispute by negotiation. This paragraph does not apply to an application for urgent interlocutory relief. (b) A party to this contract claiming that a dispute has arisen from the Agreement (“the Dispute”) must give written notice specifying the nature of the Dispute (“the Notice”) to the other party or parties to the Agreement. The parties must then participate in mediation in accordance with this clause. (c) The parties must select a mediator approved by the Law Society of Queensland who will arrange mediation. (d) The parties will bear their own costs in respect legal proceedings and mediation and cannot receive these from the other party. (e) If a mediator fails to be agreed within 30 days, the parties may commence court or arbitration proceeding. 27. COOPERATION The Third Party will cooperate, to the extent it is able, with RLSSQ and ASQA and provide accurate responses to reasonable requests about delivery of Training in respect to any audit by ASQA or RLSSQ. The Third Party will provide verbal and/or written responses within seven (7) days, and provide any requested documents within seven (7) days subject to any legislative restrictions on the Third Party providing the information.
Privacy Authority. The Trainer hereby irrevocably authorise RLSSQ to provide information (both verbal and written) and any document in respect to the Trainer: • in a public forum or on social media, • to ASQA or any related training authority, • to our other trainers, contractors, business partners & affiliates, and/or • to any government agency (including the ACNC and the State & Federal Governments) as RLSSQ considered is necessary for the operation and reporting of RLSSQ. 28. DISPUTE RESOLUTION (a) If a dispute arises from this contract, a party to the contract must not commence court or arbitration proceedings relating to the dispute unless that party has participated in mediation in accordance with paragraphs (b) and (c) of this clause. This paragraph does not apply to an application for urgent interlocutory relief. (b). A party to this contract claiming that a dispute has arisen from the Agreement (“the Dispute”) must give written notice specifying the nature of the Dispute (“the Notice”) to the other party or parties to the Agreement. The parties must then participate in mediation in accordance with this clause. (c) The parties must select a mediator approved by the Law Society of Queensland who will arrange mediation. (d) The parties will bear their own costs in respect legal proceedings and mediation and cannot receive these from the other party. (e) If a mediator fails to be agreed within 30 days, the parties may commence court or arbitration proceeding.
Privacy Authority. 11.1. Where the Purchaser applies for credit with Xxxxxxx, the Purchaser agrees and authorises Xxxxxxx to make such enquiries as Xxxxxxx deems necessary to assess the Purchaser’s application for credit. The Purchaser further agrees and authorises Xxxxxxx against a manufacturer of the Goods; and (b) no other warranties express or implied are given unless they are expressly given by Xxxxxxx in writing.
Privacy Authority. 17.1. Where the Purchaser applies for credit with Xxxxxxx, the Purchaser agrees and authorises Xxxxxxx to make such enquiries as Xxxxxxx deems necessary to assess the Purchaser’s application for credit. The Purchaser further agrees and authorises Xxxxxxx to the extent permitted by law to provide any items of Personal Data described in the Data Protection Legislation to a credit reporting agency inside or outside the United Kingdom and give credit worthiness information about the Purchaser to a person for considering whether to act as a guarantor or to a guarantor.
AutoNDA by SimpleDocs
Privacy Authority. Distributor irrevocably authorizes EnteroMedics, its employees and agents to make such inquiries as it deems necessary to investigate the creditworthiness or other information requirements of Distributor from time to time including the making of inquiries of persons that are trade references, the bankers of Distributor or any other credit providers (collectively the “Information Sources”) and Distributor hereby authorizes the Information Sources to disclose to EnteroMedics such information concerning Distributor.

Related to Privacy Authority

  • Government Authorizations No Consent of, with or to any Governmental Authority is required to be obtained or made by or with respect to Buyer or any of its Affiliates in connection with the execution and delivery of this Agreement and the other Transaction Documents by Buyer or the consummation by Buyer of the transactions contemplated hereby and thereby, except for (a) required filings under the HSR Act, (b) as set forth on Section 5.4 of the Buyer Disclosure Schedule, and (c) Consents not required to be made or given until after Closing.

  • Privacy Act If performance involves design, development or operation of a system of records on individuals, this Agreement incorporates by reference FAR 52.224-1 Privacy Act Notification (Apr 1984) and FAR 52.224-2 Privacy Act (Apr 1984).

  • FDA As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a “Pharmaceutical Product”), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!